We are a consortium of clinicians, basic and translational scientists, patient associations, startups and pharmaceutical companies focused on the key clinical, scientific and educational areas of chronic pain.
SCIENTISTS
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
CLINICIANS
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
COMPANIES
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
ASSOCIATIONS
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
MISSION
Map the most pressing challenges associated with chronic pain symptoms after COVID-19
Build knowledge on specific aspects of post-COVID chronic pain syndrome (PCPS)
Identify and discuss current clinical gaps
Propose new possible diagnostic tools and therapeutic solutions
Build a comprehensive approach to the understanding of PCPS pathophysiology
Discover new diagnostic and prognostic biomarkers
Explore future clinical therapeutic solutions for widespread chronic pain syndromes
Have a beneficial impact on the quality of life of PCPS patients